These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1490923)

  • 21. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
    N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of comparative studies between conventional and liposomal amphotericin B (Ambisome) in neutropenic patients with fever of unknown origin and patients with systemic mycosis.
    Blau IW; Fauser AA
    Mycoses; 2000 Oct; 43(9-10):325-32. PubMed ID: 11105535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever.
    Ellis M; Bernsen R; Ali-Zadeh H; Kristensen J; Hedström U; Poughias L; Bresnik M; Al-Essa A; A Stevens D
    J Med Microbiol; 2009 Nov; 58(Pt 11):1474-1485. PubMed ID: 19589901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT; Dittmer M; Ostermann H
    Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication.
    Oto OA; Paydas S; Disel U; Yavuz S; Seydaoglu G
    Mycoses; 2007 Mar; 50(2):135-9. PubMed ID: 17305778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with multilamellar liposomal amphotericin B in patients with proven and suspected fungal infections.
    Ralph ED; Barber KR; Grant CW
    Scand J Infect Dis; 1993; 25(4):487-96. PubMed ID: 8248749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of deep mycoses with liposomal amphotericin B.
    Berenguer J; Muñoz P; Parras F; Fernández-Baca V; Hernández-Sampelayo T; Bouza E
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):504-7. PubMed ID: 7957273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intralipid in prophylaxis of amphotericin B nephrotoxicity.
    Vita E; Schroeder DJ
    Ann Pharmacother; 1994 Oct; 28(10):1182-3. PubMed ID: 7841575
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India.
    Jadhav MP; Shinde VM; Chandrakala S; Jijina F; Menon H; Arora B; Kurkure PA; Parikh PM; Kshirsagar NA
    Indian J Cancer; 2012; 49(1):107-13. PubMed ID: 22842177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
    Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary invasive aspergillosis: value of treatment with intravenous amphotericin B administered in a triglyceride emulsion for parenteral usage].
    Andrès E; Limacher JM; Bergerat JP
    Rev Med Interne; 1994 Apr; 15(4):244-9. PubMed ID: 8059144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
    White MH; Bowden RA; Sandler ES; Graham ML; Noskin GA; Wingard JR; Goldman M; van Burik JA; McCabe A; Lin JS; Gurwith M; Miller CB
    Clin Infect Dis; 1998 Aug; 27(2):296-302. PubMed ID: 9709879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline.
    Branch RA; Jackson EK; Jacqz E; Stein R; Ray WA; Ohnhaus EE; Meusers P; Heidemann H
    Klin Wochenschr; 1987 Jun; 65(11):500-6. PubMed ID: 3475498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact on renal function of an early switch from conventional to liposomal amphotericin B formulation in the empirical treatment of fungal infections].
    Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Monchecourt F; Mahi L; Deray G
    Med Mal Infect; 2008 Apr; 38(4):208-14. PubMed ID: 18191521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
    Wingard JR; White MH; Anaissie E; Raffalli J; Goodman J; Arrieta A;
    Clin Infect Dis; 2000 Nov; 31(5):1155-63. PubMed ID: 11073745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.
    Caillot D; Chavanet P; Casasnovas O; Solary E; Zanetta G; Buisson M; Wagner O; Cuisenier B; Bonnin A; Camerlynck P
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):722-5. PubMed ID: 1425731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex.
    Kline S; Larsen TA; Fieber L; Fishbach R; Greenwood M; Harris R; Kline MW; Tennican PO; Janoff EN
    Clin Infect Dis; 1995 Nov; 21(5):1154-8. PubMed ID: 8589135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial.
    Eriksson U; Seifert B; Schaffner A
    BMJ; 2001 Mar; 322(7286):579-82. PubMed ID: 11238151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.